parkinson: Network Meta-Ananlysis on Parkinson's Disease
In pcnetmeta: Patient-Centered Network Meta-Analysis
parkinson R Documentation
Network Meta-Ananlysis on Parkinson's Disease
Description
An example of network meta-analysis for continuous outcomes.
Usage
data("parkinson")
Format
A data frame containing 7 studies which compare 5 treatments.
s.ida numeric vector of study IDs.
t.ida numeric vector of treatment IDs.
meana numeric vector of the mean of continuous outcomes in each treatment group in each study.
sda numeric vector of the standard deviance of continuous outcomes in each treatment group in each study.
na numeric vector of the total number of participants in each treatment group in each study.
Details
The continuous outcome measures the off-time reduction in patients given dopamine agonists as adjunct therapy in Parkinson's disease. Treatment 1 is placebo and treatments 2 to 5 are active drugs.
Source
Dias S, Sutton AJ, Ades AE, Welton NJ (2013). "Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials." Medical Decision Making, 33(5), 607–617. <doi: 10.1177/0272989X12458724>
pcnetmeta documentation built on Aug. 31, 2022, 9:08 a.m.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
| parkinson | R Documentation |
Network Meta-Ananlysis on Parkinson's Disease
Description
An example of network meta-analysis for continuous outcomes.
Usage
data("parkinson")
Format
A data frame containing 7 studies which compare 5 treatments.
s.ida numeric vector of study IDs.
t.ida numeric vector of treatment IDs.
meana numeric vector of the mean of continuous outcomes in each treatment group in each study.
sda numeric vector of the standard deviance of continuous outcomes in each treatment group in each study.
na numeric vector of the total number of participants in each treatment group in each study.
Details
The continuous outcome measures the off-time reduction in patients given dopamine agonists as adjunct therapy in Parkinson's disease. Treatment 1 is placebo and treatments 2 to 5 are active drugs.
Source
Dias S, Sutton AJ, Ades AE, Welton NJ (2013). "Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials." Medical Decision Making, 33(5), 607–617. <doi: 10.1177/0272989X12458724>
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Embedding an R snippet on your website
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.